VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer. Clin Cancer Res. 2017 May 15; 23(10):2542-2555.
View in:
PubMed
subject areas
Acetylation
Cell Line, Tumor
Clinical Trials as Topic
Gene Expression Regulation, Leukemic
Histone Deacetylase 1
Histone Deacetylase Inhibitors
Humans
Kruppel-Like Transcription Factors
Neoplasms
Protein Binding
Proto-Oncogene Proteins c-myc
Signal Transduction
Sp1 Transcription Factor
TNF-Related Apoptosis-Inducing Ligand
authors with profiles
GUILLERMO GARCIA-MANERO